Medical Technology Venture Partners — Full Portfolio
4 tracked investments · listed companies and verified rows first
Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions.
Digital HealthHardwareHealthtechMedical DevicesOmaha, US
Evan Luxon(Executive Officer, Director)inRandy Preston(CEO)Alan Chesler(Director)Dan Burnett(Director)
BoardDaniel Burnett(Director)
Board seatRadu Cautis· per SEC Form D
Co-investorsInvest NebraskaNew York AngelsScientific Health Development
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)James Leech(Executive Officer)Matthew E. Likens(Executive Officer, Director)
BoardGeoff Pardo(Director)inPrattipati Laxminarain(Director)
Board seatRadu Cautis· per SEC Form D · $45.1M raise · filed Mar 2023
Co-investorsAccelmed PartnersFemHealth VenturesBlueStone Venture PartnersEvidity Health CapitalGilde HealthcareMedTech Venture Partners+2 more
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)John Beck(Executive Officer)
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Board seatRadu Cautis· per SEC Form D · $32.2M raise · filed Dec 2017
Co-investorsAstiaF-Prime CapitalShangBay Capital LLCY CombinatorDorm RoomGolden Seeds
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.